CD20‐TCB (RG6026), A NOVEL “2:1” FORMAT T‐CELL‐ENGAGING BISPECIFIC ANTIBODY, INDUCES COMPLETE REMISSIONS IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN'S LYMPHOMAM.J. Dickinson,F. Morschhauser,G. Iacoboni,C. Carlo‐Stella,F.C. Offner,A. Sureda,G. Salles,J. Martinez, M. Crump,D.N. Thomas,P.N. Morcos,C. Ferlini, A. Broeske,M. Bacac,N.J. Dimier, P. Umaña, T. Moore,M. Weisser,M. HutchingsHematological Oncology（2019）引用 15|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
